Clinical impact of integrated PET/CT on the management of suspected cervical cancer recurrence
- 1 March 2007
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 104 (3) , 529-534
- https://doi.org/10.1016/j.ygyno.2006.09.009
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Detection of recurrent cervical cancer by whole-body FDG PET scan in asymptomatic and symptomatic womenGynecologic Oncology, 2004
- Positron emission tomography for unexplained elevation of serum squamous cell carcinoma antigen levels during follow‐up for patients with cervical malignanciesCancer, 2004
- Restaging of recurrent cervical carcinoma with dual‐phase [18F]fluoro‐2‐deoxy‐D‐glucose positron emission tomographyCancer, 2004
- Staging of Non–Small-Cell Lung Cancer with Integrated Positron-Emission Tomography and Computed TomographyNew England Journal of Medicine, 2003
- Is carcino-embryonic antigen useful in the follow-up management of patients with colorectal liver metastases?The American Journal of Surgery, 1999
- Benign causes of 18-FDG uptake on whole body imagingSeminars in Nuclear Medicine, 1998
- Surgical management of locally recurrent rectal cancerBritish Journal of Surgery, 1996
- Second-look operation for recurrent colorectal cancer based on carcinoembryonic antigen and imaging techniquesDiseases of the Colon & Rectum, 1996
- Recurrent cervical carcinoma after radical hysterectomyGynecologic Oncology, 1988
- Histologic grade and lymph node metastasis in squamous cell carcinoma of the cervixGynecologic Oncology, 1981